Haga SB - Search Results

1

A stepwise approach to implementing pharmacogenetic testing in the primary care setting.

Weitzel KW, Duong BQ, Arwood MJ, Owusu-Obeng A, Abul-Husn NS, Bernhardt BA, Decker B, Denny JC, Dietrich E, Gums J, Madden EB, Pollin TI, Wu RR, Haga SB, Horowitz CR. Weitzel KW, et al. Among authors: haga sb. Pharmacogenomics. 2019 Oct;20(15):1103-1112. doi: 10.2217/pgs-2019-0053. Pharmacogenomics. 2019. PMID: 31588877 Free PMC article.

2

Pharmacogenetic testing: not as simple as it seems.

Haga SB, Burke W. Haga SB, et al. Genet Med. 2008 Jun;10(6):391-5. doi: 10.1097/GIM.0b013e31817701d4. Genet Med. 2008. PMID: 18496219 Free article.

3

Factors influencing uptake of pharmacogenetic testing in a diverse patient population.

O'Daniel J, Lucas J, Deverka P, Ermentrout D, Silvey G, Lobach DF, Haga SB. O'Daniel J, et al. Among authors: haga sb. Public Health Genomics. 2010;13(1):48-54. doi: 10.1159/000217795. Epub 2009 May 4. Public Health Genomics. 2010. PMID: 19407441

4

Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling.

Haga SB, Carrig MM, O'Daniel JM, Orlando LA, Killeya-Jones LA, Ginsburg GS, Cho A. Haga SB, et al. J Gen Intern Med. 2011 Aug;26(8):834-40. doi: 10.1007/s11606-011-1651-7. Epub 2011 Feb 11. J Gen Intern Med. 2011. PMID: 21311998 Free PMC article.

5

Survey of US public attitudes toward pharmacogenetic testing.

Haga SB, O'Daniel JM, Tindall GM, Lipkus IR, Agans R. Haga SB, et al. Pharmacogenomics J. 2012 Jun;12(3):197-204. doi: 10.1038/tpj.2011.1. Epub 2011 Feb 15. Pharmacogenomics J. 2012. PMID: 21321582 Free PMC article.

6

Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.

Haga SB, O'Daniel JM, Tindall GM, Lipkus IR, Agans R. Haga SB, et al. Genet Med. 2011 Aug;13(8):723-8. doi: 10.1097/GIM.0b013e31821afcc0. Genet Med. 2011. PMID: 21633294 Free PMC article.

7

Public perspectives about pharmacogenetic testing and managing ancillary findings.

Haga SB, Tindall G, O'Daniel JM. Haga SB, et al. Genet Test Mol Biomarkers. 2012 Mar;16(3):193-7. doi: 10.1089/gtmb.2011.0118. Epub 2011 Nov 2. Genet Test Mol Biomarkers. 2012. PMID: 22047505 Free PMC article.

8

Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.

Haga SB, O'Daniel JM, Tindall GM, Mills R, Lipkus IM, Agans R. Haga SB, et al. Clin Genet. 2012 Aug;82(2):115-20. doi: 10.1111/j.1399-0004.2012.01848.x. Epub 2012 Feb 19. Clin Genet. 2012. PMID: 22283474 Free PMC article.

9

Primary care physicians' knowledge of and experience with pharmacogenetic testing.

Haga SB, Burke W, Ginsburg GS, Mills R, Agans R. Haga SB, et al. Clin Genet. 2012 Oct;82(4):388-94. doi: 10.1111/j.1399-0004.2012.01908.x. Epub 2012 Jul 3. Clin Genet. 2012. PMID: 22698141 Free PMC article.

10

Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists.

Mills R, Haga SB. Mills R, et al. Among authors: haga sb. Pharmacogenomics. 2013 Jun;14(8):957-68. doi: 10.2217/pgs.13.76. Pharmacogenomics. 2013. PMID: 23746189 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page